STAT3 and cardiac hypertrophy: We engineered AAV9 viral vectors controlled by the cardiomyocyte‐specific cTnT promoter to knock down Stat3 in cardiomyocytes and determined its role in improving cardiac hypertrophy mediated by ECSIT‐X4 in vivo.